Drrx stock forecast.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ...

Drrx stock forecast. Things To Know About Drrx stock forecast.

What is the current Price Target and Forecast for DURECT (DRRX) DURECT (DRRX) (Delayed Data from NSDQ) $0.66 USD +0.01 (1.54%) Updated Nov 24, 2023 12:59 PM …DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66.The DRRX shares have gain 15.52% over the last week, with a monthly amount drifted -79.02%, and not seem to be holding Durect Corp [DRRX] stock prices are up 0.44% to $0.61 at the moment. One of the good ways to gauge the recent performance is if the stock's short-term value is rising or falling.Overall, the bulls take the lead on this one. Out of 5 total reviews published in the last three months, all 5 analysts rated the stock a Buy. Therefore, the message is clear: AVDL is a Strong Buy ...

Forecast . Price target. 19.38 0.00 0.00%. The 4 analysts offering 1 year price forecasts for DRRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 4 analysts giving stock ratings to DRRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreAnalyst Price Forecast Suggests 611.06% Upside. As of ... The put/call ratio of DRRX is 2.39, ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K shares representing 27.10% ...Research DURECT's (Nasdaq:DRRX) stock key valuation metrics while comparing it with its industry peers & market side by side. Research DURECT's ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts ...

You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis. So, if you’re still on the fence about whether DURECT Corp is a buy, sell or hold, you can utilize AAII’s expansive and robust screening tools like A+ Investor to help with your decision.

A. The latest price target for Durect ( NASDAQ: DRRX) was reported by JonesTrading on Thursday, November 9, 2023. The analyst firm set a price target for 0.00 expecting DRRX to fall to within 12 ...Durect Corp. analyst ratings, historical stock prices, earnings estimates & actuals. DRRX updated stock price target summary.Real time Durect (DRRX) stock price quote, stock graph, news & analysis.About CohBar Stock (NASDAQ:CWBR) CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; …

Durect Stock Prediction. AVB. 40

The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...

Jul 20, 2023 · /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant. 1.82%. $205.6M. Acura Pharmaceuticals Inc. 0.00%. $66. DRRX | Complete Durect Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ...marketbeat.com - June 2 at 4:40 AM. Tocqueville Asset Management L.P. Has $316,000 Position in DURECT Co. (NASDAQ:DRRX) marketbeat.com - May 19 at 7:46 AM. Analysts Offer Insights on Healthcare Companies: Durect (DRRX), Pfizer (PFE) and BioVie (BIVI) markets.businessinsider.com - May 18 at 8:46 AM.As of Nov 17, 2023, it costs $0.61 to buy one share of Durect stock. Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.31, you can buy 0.5 shares of DRRX. Get Started with eToro Today. eToro is a multi-asset investment platform.Oct 19, 2023 · The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...

DURECT Announces 1-for-10 Reverse Stock Split. CUPERTINO, Calif., Nov. 28, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX ), a biopharmaceutical company focused on developing epigenetic ...Durect Stock Chart and Share Price Forecast, Short-Term "DRRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Durect Corp (DRRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 Find the latest Earnings Report Date for DURECT Corporation Common Stock (DRRX) at Nasdaq.com. Skip ... Read our earnings report guide before you consider the forecast information when ...DRRX's stock price has decreased by -84.09% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 2 stock analysts, the average 12-month stock price forecast for DURECT stock is $36.5, which predicts an increase of 5,499.88%.DSAC stock forecast for 2023 – 2027. Last updated: November 22, 2023. Are you interested in Duddell Street Acquisition Corp. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the DSAC stock price in …

Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. ... Latest Stock Analysis. Follow $0.66 0.01 (+1 ...

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update. Durect Earnings Preview. Track Durect Corp (DRRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.DURECT stock forecast: Based on undefined Wall Street analysts` predicted price targets for DURECT in the last 3 months, the avarage price target is $NaN, with a high ...3 analysts have issued 12-month price objectives for Broadwind's stock. Their BWEN share price targets range from $6.00 to $9.00. On average, they predict the company's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 250.1% from the stock's current price. View analysts price targets for BWEN or view top ...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median... "DRRX" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "DRRX" projections. At Walletinvestor.com we …Dec 1, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... Get the latest Marker Therapeutics Inc (MRKR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions./PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant.The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...Broadly, the S&P’s financial sector is down 2% year-to-date, making it the worst-performing sector, followed by energy (down 8%), utilities (8%) and healthcare (3%). Pharmaceutical giant Pfizer ...

A high-level overview of DURECT Corporation (DRRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Institutional Ownership and Shareholders. Durect Corp (US:DRRX) has 4 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 404,520 shares. Largest shareholders include Jefferies Group LLC, Montchanin Asset Management, Llc, and Regis …

DSAC stock forecast for 2023 – 2027. Last updated: November 22, 2023. Are you interested in Duddell Street Acquisition Corp. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the DSAC stock price in …Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00.When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Durect (NASDAQ: DRRX) is one of my favorite cheap stocks to buy right now. It’s current price looks even more tempting given the company completed a 1-to-10 stock split late last year. Durect is ...Find the latest CPS Technologies Corporation (CPSH) stock quote, history, news and other vital information to help you with your stock trading and investing.The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ...As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.7 Nov 2023 ... Stock DRRX logo. DRRX · DURECT Corporation Announces Topline Results ... stock at the public offering price, less underwriting discounts and ...DRRX, Durect - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. RESEARCH. Shopping Cart. Your cart is ... Durect (DRRX) - Develops pharmaceuticals for chronic pain and central nervous system disorders. GROUP LEADERSHIP Medical-Biomed/Biotech Group. DRRX. is not ranked …

View the latest DRRX earnings date, analysts forecasts, earnings history, ... What is DURECT's EPS forecast for next year? DURECT's earnings are expected to grow from ($1.46) per share to ($1.24) per share in the next year. ... Stock Ideas and Recommendations.Broadly, the S&P’s financial sector is down 2% year-to-date, making it the worst-performing sector, followed by energy (down 8%), utilities (8%) and healthcare (3%). Pharmaceutical giant Pfizer ...Cascades deeply regrets and is saddened to announce the death of one of its cofounders, Mr. Bernard Lemaire, at the age of 87. Find the latest Cascades Inc. (CAS.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. best cash advance appaphenomex stockwhen does pre order start for iphone 15slyv etf Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00.Mar-09-21 09:00AM. DURECT Corporation Announces Publication of DUR-928's Mechanism of Action. (PR Newswire) DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic … fractals forexbest low price stocks Nov 8, 2023 · Durect Corp (DRRX) $0.66 0.01 (1.54%) 13:00 EST DRRX Stock Quote Delayed 30 Minutes. Stock Price Forecast The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 34.50, with a high estimate of 44.00 and a low estimate of 32.00. The median estimate represents a +984.91% increase from the last price of 3.18. how much is a 50 cent piece worth Mar 7, 2023 · Durect (DRRX) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.30 per share a year ago. These figures are ... DURECT (NASDAQ:DRRX) stock price plunges 31% as it entered into definitive agreements for the purchase and sale of an aggregate of 2.99M shares of common stock and warrants to purchase up to 2.99M ...